Table 2. Demographic and clinical characteristics of study population by liver/spleen ratio.

Characteristic	African American			Caucasian			Hispanic
	No NAFLD (n = 886)	NAFLD (n = 106)	p value	No NAFLD (n = 1,055	NAFLD (n = 189)	p value	No NAFLD (n = 567)	NAFLD (n = 208)	p value
Age	63.5 ± 10.1	63.4.6 ± 9.3	0.86	63.9 ± 10.8	61.5 ± 9.2	0.003	62.9 ± 10.8	59.3 ± 9.9	<0.001
Men	382 (43)	36 (34)	0.07	496 (47)	95 (50)	0.41	266 (45)	93 (41)	0.3
BMI, kg/m2	29.5 ± 5.6	32.8 ± 5.8	<0.001	27.4 ± 4.8	31.4 ± 5.1	<0.001	28.5 ± 4.4	31.7 ± 5.3	<0.001
Obese	370 (41)	72 (67)	<0.001	265 (25)	108 (57)	<0.001	186 (31)	123 (54)	<0.001
Waist (cm)	99.8 ± 13.8	109.0 ± 14.4	<0.001	96.9 ± 13.8	108.6 ± 12.8	<0.001	98.5 ± 12.2	105.3 ± 12.4	<0.001
History of smoking	453 (52)	47 (44)	0.17	538 (51)	90 (48)	0.43	256 (43)	90 (40)	0.4
Education (<high school)	111 (13)	9 (8)	0.22	55 (5)	12 (6)	0.51	325 (55)	104 (46)	0.03
Hypertension	498 (56)	66 (62)	0.20	329 (31)	93 (49)	<0.001	204 (34)	88 (39)	0.22
Total cholesterol, mg/dl	190.2 ± 35.9	189.5 ± 34.8	0.85	194.2 ± 34.0	193.8 ± 43.4	0.87	197.8 ± 35.3	197.6 ± 38.0	0.94
LDL-c, mg/dl	117.2 ± 32.1	117.0 ± 32.9	0.97	117.4 ± 29.5	114.2 ± 31.8	0.18	120.3 ± 32.4	116.8 ± 30.3	0.16
HDL-c, mg/dl	53.0 ± 15.3	47.4 ± 12.8	<0.001	51.5 ± 14.7	43.9 ± 12.8	<0.001	48.9 ± 13.8	44.1 ± 10.9	<0.001
Triglycerides, mg/dl	99.8 ± 54.3	125.0 ± 64.9	<0.001	126.3 ± 70.8	191.9 ± 191.5	<0.001	145.5 ± 82.0	185.1 ± 88.1	<0.001
Diabetes	132 (15)	23 (22)	0.07	65 (6)	20 (11)	0.08	87 (15)	47 (21)	0.03
C-reactive protein mg/dla	2.3 (1.1–5.0)	3.7 (1.7–8.4)	0.05	1.5 (0.7–3.5)	3.3 (1.5–6.2)	<0.001	2.1 (1.0–4.6)	3.4 (1.7–6.8)	0.005
HOMAa	1.2 (0.8–2.0)	2.5 (1.5–3.8)	<0.001	1.0 (0.6–1.5)	2.3 (1.4–3.5)	<0.001	1.3 (0.8–2.0)	2.5 (1.6–3.9)	<0.001

NAFLD nonalcoholic fatty liver disease, BMI body mass index

Reported as mean ± SD or number (%)

^aMedian and interquartile range reported